ICYMI, some of the content featured this week includes combination treatments for keloids, inflammatory pathways involved in rosacea pathogenesis, using smartphones to improve GEA scale assessment in patients with darker skin types, the use of artificial intelligence for evaluating acne severity, plus more.
In case you missed it, some of this week’s featured content includes using artificial intelligence for evaluating acne severity, telemedicine and its impact on patient visits, combination treatments for keloids, treating acne during COVID-19, inflammatory pathways involved in rosacea pathogenesis, using smartphones to improve GEA scale assessment in patients with darker skin types, specialized skincare regimens that may improve rosacea symptoms, plus more.
The Mainstream Patient: August 10
This week’s edition of The Mainstream Patient features stories about sun protection myths, hand sanitizer-induced eczema, at-home dermaplaning, anti-stress skincare, plus more.
AbbVie launches hidradenitis suppurativa education center for physicians
AbbVie announces the launch of their hidradenitis suppurativa-centered educational website aimed at bringing awareness and educating physicians on the disease.
Artificial intelligence algorithm effectively evaluates acne severity
The implementation of artificial intelligence technology in the long-term management and follow-up of acne patients may help to improve patient treatment outcomes.
MauiDerm Connect will live stream in September
Top educators in dermatology will come together to deliver CME lectures and engaging panel discussions via a premiere virtual platform. Learn more about MauiDerm Connect coming September 23-27.
Smartphones aid GEA scale assessment in patients with darker skin
Smartphones may provide another tool for physicians to assess acne severity in patients with darker skin types, a study shows.
How has telemedicine impacted patient visits?
Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, discusses how she approaches treating acne via virtual visits after incorporating telemedicine into her practice due to the COVID-19 pandemic.
Combination therapies improve keloid treatment
Combination therapies that integrate older therapies have shown great promise in the treatment and management of keloids.
Patient education easier via virtual visits
Virtual visits may allow providers to focus more on patient education, says Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama.
Specialized skincare regimen improves rosacea symptoms
Effects of a specialized skincare regimen for sensitive and redness-prone skin were investigated in an eight-week, prospective, controlled clinical trial enrolling 60 patients with rosacea. The intervention was associated with improvements in objectively measured erythema, rosacea symptoms, and health-related quality of life.
Will telemedicine impact the future of acne care?
Will the current practice of using telemedicine for acne care have an impact on the future of dermatology? We spoke with Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, on the topic.
Don’t forget acne patients during COVID-19
Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, emphasizes the importance of ensuring timely treatment of acne patients during the COVID-19 crisis.
Telemedicine for acne: Good or bad?
Is telemedicine a useful tool to treat acne during the COVID-19 pandemic? Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, shares her insights.
Pathophysiologic pathways provide treatment efficacy insight
Experts offer insights into the inflammatory pathways involved in rosacea pathogenesis, the putative anti-inflammatory mechanisms of action of treatments for rosacea, and future therapeutic needs.
Collaboration progresses standards for implementing AI
The International Skin Imaging Collaboration is an academic and industry partnership designed to facilitate the clinical application of digital skin imaging, with an initial focus on melanoma. The group is developing standards for dermatologic imaging and building a public archive of clinical and dermoscopic images for use in developing artificial intelligence diagnostic algorithms.
HIFU technology making waves with multiple treatment indications
A Danish dermatology company releases their new HIFU device, TOOsonix System ONE-M, for treatment of color-independent tattoo removal, spider veins, lentigines, telangiectasia, angiomas and various other aesthetic conditions.